Possibility
Explore our work: what we do, how we do it, and the value we create for our clients.
Impact
Culture
Possibility
Explore our work: what we do, how we do it, and the value we create for our clients.
Global Shifts
Empowered consumers
Healthier humans
Future organisations
Business for better
Safer societies
Sustainable world
Industries
Consumer and manufacturing
Defence and security
Energy and utilities
Financial services
Government and public sector
Health
Life sciences
Transport
Services
Set growth strategy
Build brands, products, and services
Reimagine AI, digital, and data
Improve organisational performance
Deliver complex programmes
Empower your people
Impact
Culture
Insight

Accelerate product development collaborations

Product development collaborations and alliances continue to play a vital role in growing the life sciences industry. Adding to already complex arrangements emerging technology and data companies are now being involved to help develop new medicines and therapies. There has been rapid growth in the number of deals with a focus on combination products. In order to bring new medicines and therapies to market faster it is imperative to accelerate the effectiveness of your newly formed collaboration.

Unlock value faster through accelerating product development collaborations

Accelerating products to market requires focus and flawless execution of your newly established drug development portfolio after an acquisition, merger, or co-development partnership.

Different company cultures, disparate systems, and inefficient decision-making processes stand in the ;way of accelerating benefits to patients.

So what do you need to prioritize to accelerate this process?

The most successful organizations:

  • Optimize deal-specific product development activities
  • Accelerate pre-deal planning through post-deal team enablement
  • Integrate collaboration data for improved decision-making and process optimization.

Our diverse team of experts combine innovative thinking with deep expertise to help you throughout your collaboration journey including M&A, Alliances, and Co-development agreements.

Considerations

  • What is your development and sourcing strategy?
  • Which process/ procedures will be used?
  • How are ad hoc decisions made?
  • Are you leveraging AI tools to accelerate patient enrollment?
  • Can you automate submission activities?

Together, we can help you bring your products to market faster.

We can support you with:

  • Playbooks to drive pre-deal to post-closure team enablement for Mergers, Acquisitions, Divestitures, and Alliances
  • Agile frameworks specific to product development collaborations
  • Pre-defined R&D governance models
  • Existing platform for integrating data to drive decision making
  • AI-based technologies to accelerate patient enrollment and automate AE processing and submission activities.

Explore more

Insight

Inspiring the next generation of innovators and leaders through real-life experience

London and Cambridge Springboard leads reflect on the three key things participants tell us make this approach so impactful.
Insight

How financial services firms can improve support for vulnerable customers and drive good customer outcomes

Learn best practices for identification, support, training, and governance to ensure vulnerable customers receive fair treatment.
Sustainability
Insight

Framework for success: Nail your net zero targets with programme control fundamentals

How can organisations successfully deliver impactful change in their transition to net zero?
Sustainability
Cheerful female friends studying together while sitting at table
Insight

Retraining’s role in closing the STEM gender diversity gap

Explore actionable strategies for a more inclusive workforce from our latest research.
Cheerful female friends studying together while sitting at table

Contact the team

We look forward to hearing from you.
Get in touch

Get actionable insight straight to your inbox via our monthly newsletter.